GlassScriptPhysician profile
Christian Peccora
NPI 1275853830
$10,766.43
in general payments reported to CMS, 2019-2025
39 companies · $970 in 2025
The $970 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,762 · 2020: $1,045 · 2021: $1,387 · 2022: $2,246 · 2023: $886 · 2024: $469 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,326.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,572.42 | 2019-2024 | Senza |
| Medtronic Vascular, INC. | $2,250.78 | 2019 | |
| Abbott Laboratories | $1,370.92 | 2019-2023 | Proclaim |
| Relievant Medsystems, INC. | $477.42 | 2022-2023 | Intracept |
| Medtronic, INC. | $389.33 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $381.73 | 2025 | Senza |
| Nalu Medical, INC. | $338.04 | 2022-2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $337.66 | 2020-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $314.32 | 2019-2025 | |
| Vertiflex, INC. | $300.02 | 2019 | |
| Boston Scientific Corporation | $192.59 | 2021-2022 | |
| Horizon Therapeutics Plc | $189.86 | 2019-2021 | |
| Medtronic USA, INC. | $177.47 | 2019 | |
| Neuronetics, INC. | $176.50 | 2023 | Neurostar Tms Therapy System |
| Collegium Pharmaceutical, INC. | $165.68 | 2019-2024 | Belbuca, Xtampza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $132.59 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $115.61 | 2023-2025 | Evoke Scs, Evoke |
| Arbor Pharmaceuticals, INC. | $90.16 | 2019-2021 | |
| Biotronik Nro, INC. | $88.56 | 2025 | Prospera |
| Painteq LLC | $68.10 | 2022-2024 | Painteq |
| Biodelivery Sciences International, INC. | $65.85 | 2020-2021 | |
| Si-Bone, INC. | $62.87 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.49 | 2022 | |
| Hikma Pharmaceuticals USA | $55.73 | 2022 | |
| Pfizer INC. | $53.41 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $48.19 | 2025 | |
| Bioventus LLC | $31.42 | 2019 | |
| Ibsa Pharma INC. | $30.08 | 2021-2025 | Flector, Licart, Tirosint |
| Elutia, INC. | $29.19 | 2020 | |
| Azurity Pharmaceuticals, INC. | $28.20 | 2024 | Horizant |
| Fujifilm Sonosite, INC. | $27.77 | 2019 | |
| Redhill Biopharma INC. | $24.23 | 2021 | |
| Electronic Waveform Lab, INC. | $23.30 | 2022 | |
| Amgen INC. | $22.78 | 2020 | |
| Grt US Holding, INC. | $21.69 | 2021 | |
| Fidia Pharma USA INC. | $13.61 | 2025 | Hymovis |
| Zyla Life Sciences, INC. | $13.55 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.03 | 2022 | |
| Vertos Medical, INC. | $12.28 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Peccora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.